LncRNA DLX6-AS1 Contributes to Epithelial–Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis

por Du, Chuang, Wang, Yan, Zhang, Yingying, Zhang, Jianhua, Zhang, Linfeng, Li, Jingruo
Publicado 2020

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis

por Zhang, Jianhua, Du, Chuang, Zhang, Linfeng, Wang, Yan, Zhang, Yingying, Li, Jingruo
Publicado 2021

Hsa_circRNA_102229 facilitates the progression of triple‐negative breast cancer via regulating the miR‐152‐3p/PFTK1 pathway

por Du, Chuang, Zhang, Jianhua, Zhang, Linfeng, Zhang, Yingying, Wang, Yan, Li, Jingruo
Publicado 2021

Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287()

por Wang, Yan, Li, Jingruo, Du, Chuang, Zhang, Linfeng, Zhang, Yingying, Zhang, Jianhua, Wang, Liuxing
Publicado 2019

Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)

por Wang, Yanyan, Zhu, Mingzhi, Li, Jingruo, Xiong, Youyi, Wang, Jing, Jing, Haihong, Gu, Yuanting
Publicado 2021

CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling

por Wang, Fang, Wang, Xiaochun, Li, Jingruo, Lv, Pengwei, Han, Mingli, Li, Lin, Chen, Zhuo, Dong, Lingling, Wang, Nan, Gu, Yuanting
Publicado 2021

Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling

por Wang, Fang, Wang, Xiaochun, Li, Jingruo, Lv, Pengwei, Han, Mingli, Li, Lin, Chen, Zhuo, Dong, Lingling, Wang, Nan, Gu, Yuanting
Publicado 2021

Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer

por Wang, Fang, Li, Jingruo, Li, Lin, Chen, Zhuo, Wang, Nan, Zhu, Mingzhi, Mi, Hailong, Xiong, Youyi, Guo, Guangcheng, Gu, Yuanting
Publicado 2022

Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis

por Mao, Xiaoyun, Lv, Pengwei, Gong, Yiping, Wu, Xiujuan, Tang, Peng, Wang, Shushu, Zhang, Dianlong, You, Wei, Wang, Ouchen, Zhou, Jun, Li, Jingruo, Jin, Feng
Publicado 2022

Patient Management Strategies in Perioperative, Intraoperative, and Postoperative Period in Breast Reconstruction With DIEP-Flap: Clinical Recommendations

por Chen, Kuo, Beeraka, Narasimha M., Sinelnikov, Mikhail Y., Zhang, Jin, Song, Dajiang, Gu, Yuanting, Li, Jingruo, Reshetov, I. V., Startseva, O. I., Liu, Junqi, Fan, Ruitai, Lu, Pengwei
Publicado 2022

Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study

por Mi, Yin, Lv, Pengwei, Wang, Fang, Li, Lin, Zhu, Mingzhi, Wang, Yanyan, Zhang, Yingying, Liu, Lele, Cao, Qinchen, Dong, Meilian, Shi, Yonggang, Fan, Ruitai, Li, Jingruo, Gu, Yuanting, Zuo, Xiaoxiao
Publicado 2020

Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study

por Wang, Xin, Feng, Kexin, Wang, Wenyan, Meng, Xiangzhi, Liu, Jiaqi, Yang, Yang, Zhong, Yuting, Li, Jingruo, Wu, Shikai, Li, Minghui, Ma, Pan, Feng, Qinfu, Zeng, Hongmei, Gu, Yuanting, Li, Xiru, Fan, Zhaoqing, Wang, Xiang
Publicado 2022